Serveur d'exploration sur les relations entre la France et l'Australie - Analysis (Canada)

Index « Auteurs » - entrée « Monica Slavin »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Monica Sender < Monica Slavin < Monica Stavarachi  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 2.
Ident.Authors (with country if any)Title
000309 (2017) Carlos Solano [Espagne] ; Monica Slavin [Australie] ; Alissa J. Shaul [États-Unis] ; David I. Marks [Royaume-Uni] ; Catherine Cordonnier [France] ; Oliver A. Cornely [Allemagne] ; Antonio Pagliuca [Royaume-Uni] ; Lael Cragin [États-Unis] ; Isidro Jarque [Espagne] ; Carolina Garcia-Vidal [Espagne] ; Sonja Sorensen [États-Unis] ; David J. Vanness [États-Unis] ; Claudie Charbonneau [France] ; Jon Andoni Barrueta [Espagne] ; Carmen Peral [Espagne] ; Marina De Salas-Cansado [Espagne] ; Eric J. Bow [Canada]Economic evaluation of azoles as primary prophylaxis for the prevention of invasive fungal infections in Spanish patients undergoing allogeneic haematopoietic stem cell transplant.
000971 (2015) Rosemary Barnes [Royaume-Uni] ; Stephanie Earnshaw [États-Unis] ; Raoul Herbrecht [France] ; Orla Morrissey [Australie] ; Monica Slavin [Australie] ; Eric Bow [Canada] ; Cheryl Mcdade [États-Unis] ; Claudie Charbonneau [France] ; David Weinstein [France] ; Michal Kantecki [France] ; Haran Schlamm [États-Unis] ; Johan Maertens [Belgique]Economic Comparison of an Empirical Versus Diagnostic-Driven Strategy for Treating Invasive Fungal Disease in Immunocompromised Patients.

List of associated KwdEn.i

Nombre de
documents
Descripteur
2Antifungal Agents (economics)
2Antifungal Agents (therapeutic use)
2Humans
2Voriconazole (therapeutic use)
1Adult
1Amphotericin B (economics)
1Amphotericin B (therapeutic use)
1Aspergillosis (diagnosis)
1Aspergillosis (drug therapy)
1Aspergillosis (economics)
1Aspergillus (isolation & purification)
1Cost Savings
1Cost-Benefit Analysis
1Decision Support Techniques
1Decision Trees
1Deoxycholic Acid (economics)
1Deoxycholic Acid (therapeutic use)
1Drug Combinations
1Echinocandins (economics)
1Echinocandins (therapeutic use)
1Febrile Neutropenia (microbiology)
1Fluconazole (economics)
1Fluconazole (therapeutic use)
1Health Care Costs
1Health Resources (economics)
1Health Resources (utilization)
1Hematopoietic Stem Cell Transplantation
1Immunocompromised Host
1Invasive Fungal Infections (economics)
1Invasive Fungal Infections (ethnology)
1Invasive Fungal Infections (microbiology)
1Invasive Fungal Infections (prevention & control)
1Itraconazole (economics)
1Itraconazole (therapeutic use)
1Lipopeptides
1Mannans (analysis)
1Spain
1Survival Rate
1Triazoles (economics)
1Triazoles (therapeutic use)
1Voriconazole (economics)

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/Canada/Analysis
HfdIndexSelect -h $EXPLOR_AREA/Data/Canada/Analysis/Author.i -k "Monica Slavin" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Canada/Analysis/Author.i  \
                -Sk "Monica Slavin" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Canada/Analysis/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Asie
   |area=    AustralieFrV1
   |flux=    Canada
   |étape=   Analysis
   |type=    indexItem
   |index=    Author.i
   |clé=    Monica Slavin
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Dec 5 10:43:12 2017. Site generation: Tue Mar 5 14:07:20 2024